Mario Draghi’s report, a focus on the proposed actions for the pharma sector
by Giuliana Miglierini The report on the Future of European competitiveness was presented by Mario Draghi on 17…
The new European Supply Chain Law and a Transatlantic partnership
September 6, 2024 by Giuliana Miglierini The new EU Corporate Sustainability Due Diligence Directive (EU) 2024/1760 (CSDDD), also…
Accelerating Clinical Trials in the European Union (ACT-EU)
The Multistakeholder Platform (MSP) and the position of the European Industrial Pharmacists Group (EIPG) by Rebecca Rebecca Stanbrook…
A study on the reprocessing and reusing of single-use devices
by Giuliana Miglierini Reprocessing and reusing are one of the key actions central to many new EU policies…
Reform of pharma legislation: the debate on regulatory data protection
by Giuliana Miglierini As the definition of the final contents of many new pieces of the overall revision…
Environmental sustainability: the EIPG perspective
Piero Iamartino Although the impact of medicines on the environment has been highlighted since the 70s of the…